Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2009
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine
Jame Abraham, Maureen Edgerly, Richard Wilson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2011
(111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents
Maya Lodish, Urania Dagalakis, Clara C Chen, et al.
Cancer Chemotherapy and Pharmacology
|
October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)
Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
JTCVS Techniques
|
April 17, 2025
Complex pediatric neoplasms: The role of congenital cardiothoracic surgery
Lindsay J Nitsche, Colleen E Bontrager, Paul J Devlin, et al.
Cancer Chemotherapy and Pharmacology
|
January 22, 2016
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy
Araz Marachelian, Ami Desai, Frank Balis, et al.
Pediatric Blood & Cancer
|
July 27, 2025
Anti-Tumor Activity of Paclitaxel-Containing Regimens in Recurrent/Refractory Wilms Tumor
Alissa Groisser, Amy Frantz, James I Geller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2004
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma
Susan E Bates, Susan Bakke, Min Kang, et al.
Blood
|
April 4, 2002
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy
Wyndham H Wilson, Michael L Grossbard, Stefania Pittaluga, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 20, 2021
Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Frank Balis, Daniel M Green, Clarke Anderson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 5, 2025
Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Frank Balis, Daniel M Green, Amy Armstrong, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 7, 2009
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine
Jame Abraham, Maureen Edgerly, Richard Wilson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 14, 2011
(111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents
Maya Lodish, Urania Dagalakis, Clara C Chen, et al.
Cancer Chemotherapy and Pharmacology
|
October 23, 2020
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212)
Emily Greengard, Yael P Mosse, Xiaowei Liu, et al.
JTCVS Techniques
|
April 17, 2025
Complex pediatric neoplasms: The role of congenital cardiothoracic surgery
Lindsay J Nitsche, Colleen E Bontrager, Paul J Devlin, et al.
Cancer Chemotherapy and Pharmacology
|
January 22, 2016
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy
Araz Marachelian, Ami Desai, Frank Balis, et al.
Pediatric Blood & Cancer
|
July 27, 2025
Anti-Tumor Activity of Paclitaxel-Containing Regimens in Recurrent/Refractory Wilms Tumor
Alissa Groisser, Amy Frantz, James I Geller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2004
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma
Susan E Bates, Susan Bakke, Min Kang, et al.
Blood
|
April 4, 2002
Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy
Wyndham H Wilson, Michael L Grossbard, Stefania Pittaluga, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 20, 2021
Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Frank Balis, Daniel M Green, Clarke Anderson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 5, 2025
Wilms Tumor, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
Frank Balis, Daniel M Green, Amy Armstrong, et al.
Page
of 2